Metabolic syndrome in antipsychotic naïve patients with schizophrenia: pooled analysis of data from three Indian studies

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Early Intervention in Psychiatry

• Publication date

  2015-10-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1111/eip.12117PMID 24438348
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Comparative study of prevalence of metabolic syndrome in bipolar disorder and schizophrenia from North India

  2014cited by this paper
• Is the prevalence of metabolic syndrome and metabolic abnormalities increased in early schizophrenia? A comparative meta-analysis of first episode, untreated and treated patients.

  2013cited by this paper
• Metabolic risk factors in first-episode schizophrenia: baseline prevalence and course analysed from the European First-Episode Schizophrenia Trial.

  2013cited by this paper
• Cardiovascular risk factors in patients with first-episode psychosis in São Paulo, Brazil.

  2012cited by this paper
• Metabolic syndrome in antipsychotic naïve patients diagnosed with schizophrenia

  2012cited by this paper
• Metabolic syndrome in schizophrenia: A comparative study of antipsychotic-free/naïve and antipsychotic-treated patients from India

  2012cited by this paper
• Drug-emergent metabolic syndrome in patients with schizophrenia receiving atypical (second-generation) antipsychotics

  2011cited by this paper
• Prevalence of Metabolic Syndrome in Urban India

  2011influential reference
• Cardiovascular risk in a first-episode psychosis sample: a 'critical period' for prevention?

  2011cited by this paper
• Metabolic syndrome among patients receiving clozapine: A preliminary estimate

  2011cited by this paper
• Effect of risperidone on metabolic parameters in antipsychotic-naïve schizophrenia: A prospective one year follow-up study.

  2011cited by this paper
• Low prevalence of obesity and metabolic syndrome in never-treated chronic schizophrenia.

  2010cited by this paper
• The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis.

  2010cited by this paper
• Metabolic Syndrome Associated with Schizophrenia and Atypical Antipsychotics

  2010cited by this paper
• 11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study).

  2009cited by this paper
• Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International As

  2009cited by this paper
• Metabolic profiles of second-generation antipsychotics in early psychosis: findings from the CAFE study.

  2009cited by this paper
• Metabolic syndrome in people with schizophrenia: a review

  2009cited by this paper
• Typical and atypical antipsychotics differentially affect long-term incidence rates of the metabolic syndrome in first-episode patients with schizophrenia: a retrospective chart review.

  2008cited by this paper
• Metabolic syndrome in first episode schizophrenia - a randomized double-blind controlled, short-term prospective study.

  2008cited by this paper
• Idiopathic Recurrent Catatonia Needs Maintenance Lorazepam: Case Report and Review

  2007cited by this paper
• Metabolic syndrome in drug-naïve first-episode psychosis treated with atypical antipsychotics.

  2007cited by this paper
• Metabolic disease and cardiovascular risk in people treated with antipsychotics in the community.

  2007cited by this paper
• Incidence of new onset metabolic syndrome with atypical antipsychotics in first episode schizophrenia: a six-week prospective study in Indian female patients.

  2007cited by this paper
• High prevalence of the metabolic syndrome among a Swedish cohort of patients with schizophrenia

  2006cited by this paper
• The Metabolic Effects of Antipsychotic Medications

  2006cited by this paper
• Prevalence of the metabolic syndrome among patients receiving clozapine.

  2006cited by this paper
• Prevalence of the metabolic syndrome in patients with schizophrenia treated with antipsychotic medication.

  2006cited by this paper
• Schizophrenia and increased risks of cardiovascular disease.

  2005cited by this paper
• A 4-fold risk of metabolic syndrome in patients with schizophrenia: the Northern Finland 1966 Birth Cohort study.

  2005cited by this paper
• Metabolic disturbance in first-episode schizophrenia

  2004cited by this paper
• The Metabolic Syndrome in Patients With Severe Mental Illnesses.

  2004cited by this paper
• The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men.

  2002cited by this paper
• Physical consequences of schizophrenia and its treatment: the metabolic syndrome.

  2002cited by this paper

• Dual jeopardy for Indian service users: Qualitative study of managing comorbid schizophrenia and diabetes mellitus

  2025cites this paper
• Anthropometric and Physiological Measures in Individuals With At‐Risk Mental State (ARMS) Compared With Individuals With Schizophrenia: Findings From a Lower Middle‐Income Country

  2025cites this paper
• Prevalence of metabolic syndrome and its associated factors in first‐treatment drug‐naïve schizophrenia patients: A large‐scale cross‐sectional study

  2024cites this paper
• Associations between metabolic disorders and sleep disturbance in patients with schizophrenia.

  2023cites this paper
• Vascular age, cardiovascular disease risk factors, and hematological parameters in patients with Schizophrenia: An exploratory study

  2022cites this paper
• The Prevalence of Metabolic Syndrome of Patients on Treatment with Haloperidol and Risperidone or Olanzapine

  2021cites this paper
• Metabolic risk factors for non-communicable diseases in Ethiopia: a systematic review and meta-analysis

  2021cites this paper
• Inflammation as a part of the pathophysiology of depression and the possibility of its influence by polyunsaturated fatty acids

  2019cites this paper
• The prevalence of metabolic syndrome in patients receiving antipsychotics in Qatar: a cross sectional comparative study

  2018cites this paper
• Treatment-Resistant Schizophrenia: Assessment and Management

  2018cites this paper
• Lipids, aggression, suicidality and impulsivity in drug-naïve/drug-free patients of schizophrenia.

  2017cites this paper
• Schizophrenie und somatische Komorbiditäten

  2017cites this paper
• Metabolic syndrome, serious mental illnesses & lifestyle

  2016cites this paper
• Metabolic syndrome in drug-naïve and drug-free patients with schizophrenia and in their siblings.

  2015cites this paper
• Drug Emergent Metabolic syndrome in patients on Antipsychotic Medication

  2015influential citation